PetMed Express, Inc. (PETS)

PetMed Express Income Statement

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Revenue	281.06	256.58	272.28	303.58	284.13
Revenue Growth (YoY)	9.54%	-5.77%	-10.31%	6.85%	0.25%
Cost of Revenue	202.42	185.84	195.34	219.27	202.88
Gross Profit	78.65	70.74	76.94	84.32	81.25
Selling, General & Admin	79.75	61.14	49.91	51.36	48.01
Other Operating Expenses	7.06	3.55	2.74	2.43	2.26
Operating Expenses	86.81	64.68	52.65	53.79	50.27
Operating Income	-8.16	6.05	24.29	30.53	30.98
Interest Expense / Income	-0.51	-0.45	1.13	0.9	0
Other Expense / Income	-1.38	-0.94	-1.03	-1.32	-2.92
Pretax Income	-6.27	7.45	24.19	30.95	33.89
Income Tax	1.19	2.31	5.47	7.03	8.04
Net Income	-7.46	5.14	18.72	23.92	25.85
Net Income Growth	-	-72.54%	-21.75%	-7.47%	-31.50%
Shares Outstanding (Basic)	20	20	20	20	20
Shares Outstanding (Diluted)	20	20	20	20	20
Shares Change	0.28%	-0.09%	1.19%	0.32%	-2.13%
EPS (Basic)	-0.37	0.25	0.93	1.19	1.29
EPS (Diluted)	-0.37	0.25	0.92	1.19	1.29
EPS Growth	-	-72.83%	-22.69%	-7.75%	-29.89%
Free Cash Flow	-0.19	22.54	16.75	37.64	36.53
Free Cash Flow Per Share	-0.01	1.11	0.83	1.88	1.82
Dividend Per Share	0.600	1.200	1.200	1.120	1.080
Dividend Growth	-50.00%	0%	7.14%	3.70%	1.89%
Gross Margin	27.98%	27.57%	28.26%	27.77%	28.60%
Operating Margin	-2.90%	2.36%	8.92%	10.06%	10.90%
Profit Margin	-2.66%	2.00%	6.87%	7.88%	9.10%
Free Cash Flow Margin	-0.07%	8.79%	6.15%	12.40%	12.86%
Effective Tax Rate	-	30.96%	22.61%	22.72%	23.73%
EBITDA	0.27	10.54	28.05	34.27	36.15
EBITDA Margin	0.10%	4.11%	10.30%	11.29%	12.72%
Depreciation & Amortization	7.06	3.55	2.74	2.43	2.26
EBIT	-6.78	7	25.32	31.85	33.89
EBIT Margin	-2.41%	2.73%	9.30%	10.49%	11.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).